(a)
(b)
Figure 4: Effect of HemoHIM on the ratio of CD4+/CD8+ T cell in cisplatin-treated mice. The blood was stained with PE-conjugated anti-mouse CD8 and FITC-conjugated anti-mouse CD4. The splenocytes were stained with PE-Cy5 conjugated anti-mouse CD3, PE-conjugated anti-mouse CD8, and FITC-conjugated anti-mouse CD4. The stained cells were acquired on FACScan. (a) The ratio of CD4+/CD8+ in splenocytes and (b) the ratio of CD4+/CD8+ in blood.